4//SEC Filing
Tardio Jason 4
Accession 0001209191-21-029041
CIK 0001636651other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 5:30 PM ET
Size
5.7 KB
Accession
0001209191-21-029041
Insider Transaction Report
Form 4
Tardio Jason
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-11-25+44,000→ 44,000 totalExercise: $3.66From: 2020-11-25Exp: 2030-05-04→ Common Stock (44,000 underlying)
Footnotes (1)
- [F1]On May 5, 2020, the Reporting Person was granted the option to purchase shares of the Issuer's common stock, subject to a performance-based vesting condition to be satisfied upon the achievement of a particular milestone related to the Issuer's clinical trial, and further subject to the Reporting Person's continuous service through such vesting date. Such option vested in full on November 25, 2020 upon the satisfaction of such performance-based vesting condition.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001794698
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 5:30 PM ET
- Size
- 5.7 KB